Development and Characterization of a Novel <i>In vivo</i> Model of Carcinoid Syndrome

Abstract

We have provided an important in vivo model to further delineate novel treatment modalities for carcinoid syndrome that will also be useful to elucidate the factors contributing to the sequelae of carcinoid disease (e.g., mesenteric fibrosis and valvular heart disease).